Therapeutic selective neck dissection (level II-V) for node-positive hypopharyngeal carcinoma: Is it oncologically safe?

Acta Oto-Laryngologica

Volumn 129, Issue 1, 2009, Pages 57-61

  Lim, Young Chang ^a,c   Lee, Jin Seok ^b   Choi, Eun Chang ^c  

^a Konkuk University School of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Hypopharynx; Node positive neck; Selective neck dissection; Squamous cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOPHARYNGEAL NEOPLASMS; KAPLAN-MEIERS ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT;

EID: 58149104307     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480802001483     Document Type: Article

References (13)

1. Kowalski LP, Santos CR, Magrin J, Scopel A. Factors influencing contralateral metastasis and prognosis from pyriform sinus carcinoma. Am J Surg 1995;170:440-5.
2. Chu PY, Wang LW, Chang SY. Surgical treatment of squamous cell carcinoma of the hypopharynx: analysis of treatment results, failure patterns, and prognostic factors. J Laryngol Otol 2004;118:443-9.
3. Chepeha DB, Hoff PT, Taylor RJ, Bradford CR, Teknos TN, Esclamado RM. Selective neck dissection for the treatment of neck metastasis from squamous cell carcinoma of the head and neck. Laryngoscope 2002;112:434-8.
4. Ambrosch P, Kron M, Pradier O, Steiner W. Efficacy of selective neck dissection: a review of 503 cases of elective and therapeutic treatment of the neck in squamous cell carcinoma of the upper aerodigestive tract. Otolaryngol Head Neck Surg 2001;124:180-7.
5. Hosal AS, Carrau RL, Johnson JT, Myers EN. Selective neck dissection in the management of the clinically node-negative neck. Laryngoscope 2000;110:2037-40.
6. Mira E, Benazzo M, Rossi V, Zanoletti E. Efficacy of selective lymph node dissection in clinically negative neck. Otolaryngol Head Neck Surg 2002;127:279-83.
7. Buckley JG, MacLennan K. Cervical node metastases in laryngeal and hypopharyngeal cancer: a prospective analysis of prevalence and distribution. Head Neck 2000;22:380-5.
8. Mercante G, Bacciu A, Oretti G, Ferri T. Involvement of level I neck lymph nodes and submandibular gland in laryngeal and/or hypopharyngeal squamous cell carcinoma. J Otolaryngol 2006;35:108-11.
9. Layland MK, Sessions DG, Lenox J. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope 2005;115:629-39.
10. Ferlito A, Shaha AR, Buckley G, Rinaldo A. Selective neck dissection for hypopharyngeal cancer in the clinically negative neck: should it be bilateral? Acta Otolaryngol 2001;121:329-35.
11. Aluffi P, Pisani P, Policarpo M, Pia F. Contralateral cervical lymph node metastases in pyriform sinus carcinoma. Otolaryngol Head Neck Surg 2006;134:650-3.
12. Prim MP, De Diego JI, Verdaguer JM, Sastre N, Rabanal I. Neurological complications following functional neck dissection. Eur Arch Otorhinolaryngol 2006;263:473-6.
13. Lohuis PJ, Klop W, Tan IB, van Den Brekel MW, Hilgers FJ, Balm AJ. Effectiveness of therapeutic (N1,N2) selective neck dissection (level II to V) in patients with laryngeal and hypopharyngeal squamous cell carcinoma. Am J Surg 2004;187:295-9.